Articles on SUD - American Society of Anesthesiologists (ASA)
  1. Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR. Risk and outcomes of substance use disorder among anesthesiology residents: a matched cohort analysis. Anesthesiology. 2015;123(4):929-936.

  2. Fry RA, Fry LE, Castanelli DJ. A retrospective survey of substance abuse in anaesthetists in Australia and New Zealand from 2004 to 2013. Anaesth Intensive Care. 2015;43(1):111-117.

  3. Schonwald G, Skipper GE, Smith DE, Earley PH. Anesthesiologists and substance use disorders. Anesth Analg. 2014;119(5):1007-1010.

  4. Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR. Substance use disorder among anesthesiology residents, 1975-2009. JAMA. 2013;310(21):2289-2296.

  5. Tetzlaff J, Collins GB, Brown DL, Leak BC, Pollock G, Popa D. A strategy to prevent substance abuse in an academic anesthesiology department. J Clin Anesth. 2010;22(2):143-150.

  6. Menk EJ, Baumgarten RK, Kingsley CP, Culling RD, Middaugh R. Success of reentry into anesthesiology training programs by residents with a history of substance abuse. JAMA. 1990;263(22):3060-3062.

  7. Gravenstein JS, Kory WP, Marks RG. Drug abuse by anesthesia personnel. Anesth Analg. 1983;62(5):467-472.

  8. Booth JV, Grossman D, Moore J, Lineberger C, Reynolds JD, Reves JG, Sheffield D. Substance abuse among physicians: a survey of academic anesthesiology programs. Anesth Analg. 2002;95(4):1024-1030.

  9. Ward CF, Ward GC, Saidman LJ. Drug abuse in anesthesia training programs. A survey: 1970-1980. JAMA. 1983;250(7):922-925.

  10. Fitzsimons MG, Baker KH, Lowenstein E, Zapol WM. Random drug testing to reduce the incidence of addiction in anesthesia residents: preliminary results from one program. Anesth Analg. 2008;107(2):630-635.

  11. Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services. Mandatory Guidelines for Federal Workplace Drug Testing Programs. 73 FR 71857. http://www.gpo.gov/fdsys/pkg/FR-2008-11-25/pdf/E8-26726.pdf.  Revised November 25, 2008. Effective March 25, 2008. Accessed June 5, 2014.

  12. Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology. 2000;93(4):922-930.

  13. Fitzsimons MG, Ishizawa Y, Baker KH. Drug testing physicians for substance of abuse: case report of a false-positive result. J Clin Anesth. 2013;25(8):669-671.

  14. Dasgupta A. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine. Am J Clin Pathol. 2007;128(3):491-503.

  15. Berge KH, Dillon KR, Sikkink KM, Taylor TK, Lanier WL. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention. Mayo Clin Proc. 2012;87(7):674-682.

  16. Schaefer MK, Perz JF. Outbreaks of infections associated with drug diversion by US health care personnel. Mayo Clin Proc. 2014;89(7):878-887.

  17. Pelton C, Ikeda RM. The California Physicians Diversion Program’s experience with recovering anesthesiologists. J Psychoactive Drugs. 1991;23(4):427-431.

  18. Paris RT, Canavan DI. Physician substance abuse impairment: anesthesiologists vs. other specialties. J Addict Dis. 1999;18(1):1-7.

  19. Rose GL, Brown RE Jr. The impaired anesthesiologist: not just about drugs and alcohol anymore. J Clin Anesth. 2010;22(5):379-384.

  20. Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology. 2000;93(4):922-930.

  21. Bryson EO. Should anesthesia residents with a history of substance abuse be allowed to continue training in clinical anesthesia? The results of a survey of anesthesia residency program directors. J Clin Anesth. 2009;21(7):508-513.

  22. Skipper GE, Campbell MD, DuPont RL. Anesthesiologists with substance use disorders: a 5-year outcome study from 16 state physician health programs. Anesth Analg. 2009;109(3):891-896.

  23. Pham JC, Pronovost PJ, Skipper GE. Identification of physician impairment. JAMA. 2013;309(20):2101-2102.

  24. Bell DM, McDonough JP, Ellison JS, Fitzhugh EC. Controlled drug misuse by Certified Registered Nurse Anesthetists. AANA J. 1999;67(2):133-140.

  25. Sgan SL, Hanzlick R. The medical review officer: a potential role for the medical examiner. Am J Forensic Med Pathol. 2003;24(4):346-350.

  26. Peat MA. Financial viability of screening for drugs of abuse. Clin Chem. 1995;41(5):805-808.

  27. Council on Scientific Affairs. Scientific issues in drug testing. JAMA. 1987;257(22):3110-3114.

  28. Pelton C, Ikeda RM. The California Physicians Diversion Program’s experience with recovering anesthesiologists. J Psychoactive Drugs. 1991;23(4):427-431.

  29. Talbott GD, Gallegos KV, Wilson PO, Porter TL. The Medical Association of Georgia’s Impaired Physicians Program. Review of the first 1000 physicians: analysis of specialty. JAMA. 1987;257(21):2927-2930.

  30. Wilson JE, Kiselanova N, Stevens Q, Lutz R, Mandler T, Tran ZV, Wischmeyer PE. A survey of inhalational anaesthetic abuse in anaesthesia training programmes. Anaesthesia. 2008;63(6):616-20.

  31. Wischmeyer PE, Johnson BR, Wilson JE, et al. A survey of propofol abuse in academic anesthesiology programs. Anesth Analg. 2007;105(4):1066-1071.

These committee work product/resources have not been approved by ASA’s Board of Directors or House of Delegates and do not represent an ASA Policy, Statement or Guideline.

Thank You Industry Supporters

Whose contributions allow the American Society of Anesthesiologists® to create world-class education and resources to improve patient care and outcomes.

Learn More